PRESS RELEASE published on 08/01/2023 at 12:30, 2 years 6 months ago Immunic to Participate in Investor and Scientific Conferences in August
PRESS RELEASE published on 06/29/2023 at 12:30, 2 years 7 months ago Immunic to Participate in Scientific and Investor Conferences in July
PRESS RELEASE published on 05/30/2023 at 12:30, 2 years 8 months ago Immunic to Participate in Scientific and Investor Conferences in June
PRESS RELEASE published on 05/17/2023 at 12:30, 2 years 8 months ago Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis
PRESS RELEASE published on 05/06/2023 at 12:30, 2 years 9 months ago Immunic Presents Clinical and Preclinical Data for IMU-856 at Digestive Disease Week 2023, Including Its Molecular Mode of Action
PRESS RELEASE published on 05/04/2023 at 12:30, 2 years 9 months ago Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders
PRESS RELEASE published on 04/27/2023 at 12:30, 2 years 9 months ago Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.
PRESS RELEASE published on 04/26/2023 at 12:30, 2 years 9 months ago Immunic to Participate in Investor and Scientific Conferences in May
PRESS RELEASE published on 04/05/2023 at 12:30, 2 years 10 months ago Immunic Reports Positive Data from Maintenance Phase of Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe Ulcerative Colitis
PRESS RELEASE published on 03/02/2023 at 12:30, 2 years 11 months ago Immunic to Participate in Investor and Scientific Conferences in March
Published on 02/10/2026 at 15:30, 1 hour 32 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 2 hours 2 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 14:30, 2 hours 32 minutes ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 3 hours 2 minutes ago Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7
Published on 02/10/2026 at 16:35, 26 minutes ago Michter's To Release Celebration Sour Mash, The Rarest Whiskey in the Distiller's Lineup
Published on 02/10/2026 at 16:15, 46 minutes ago Infinix to Deliver Industry-leading Performance with Snapdragon Platforms
Published on 02/10/2026 at 16:05, 56 minutes ago Brandwatch and Blackbird.AI Consortium Selected by NATO to Deliver Information Environment Assessment Capability
Published on 02/10/2026 at 15:30, 1 hour 32 minutes ago Nebius announces agreement to acquire Tavily to add agentic search to its AI cloud platform
Published on 02/10/2026 at 15:15, 1 hour 46 minutes ago Kasowitz and Mishcon de Reya Comment on Tirana Mayor Erion Veliaj's Year in Detention: For 365 Days and Counting, Mayor Veliaj Suffers Denials of Due Process Rights and Apparent Political Persecution
Published on 02/09/2026 at 18:00, 23 hours 2 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 23 hours 17 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 23 hours 17 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 23 hours 17 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 23 hours 17 minutes ago Déclaration des droits de vote à fin janvier 2026
